|
Volumn 105, Issue 1, 2013, Pages 2-3
|
Conflicting clinical guidelines.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
TUMOR MARKER;
ADVISORY COMMITTEE;
BLOOD;
CONFLICT OF INTEREST;
ECONOMICS;
EMOTION;
EVIDENCE BASED MEDICINE;
HEALTH ECONOMICS;
HEALTH INSURANCE;
HUMAN;
IMMUNOLOGY;
INSURANCE;
MALE;
MEDICAL SOCIETY;
NEOPLASM;
NOTE;
ORGANIZATION;
PALLIATIVE THERAPY;
PRACTICE GUIDELINE;
PROSTATE TUMOR;
STANDARD;
UNITED STATES;
ADVISORY COMMITTEES;
CONFLICT OF INTEREST;
ECONOMICS, MEDICAL;
EMOTIONS;
EVIDENCE-BASED MEDICINE;
HUMANS;
INSTITUTE OF MEDICINE (U.S.);
INSURANCE COVERAGE;
INSURANCE, HEALTH;
MALE;
NEOPLASMS;
PALLIATIVE CARE;
PRACTICE GUIDELINES AS TOPIC;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
SOCIETIES, MEDICAL;
TUMOR MARKERS, BIOLOGICAL;
UNITED STATES;
|
EID: 84874127048
PISSN: None
EISSN: 14602105
Source Type: None
DOI: 10.1093/jnci/djs630 Document Type: Note |
Times cited : (4)
|
References (0)
|